|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 438.96 USD | -0.25% |
|
-1.15% | +2.95% |
| Jan. 08 | Amphenol Corporation Appoints Sanjiv Lamba to Board of Directors | CI |
| Jan. 06 | Analyst recommendations: AT&T, BoA, Comcast, MetLife, Reddit… |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.94 | 4.05 | 5.16 | 6.45 | 6.9 | |||||
Return on Total Capital | 3.85 | 5.39 | 6.89 | 8.51 | 9 | |||||
Return On Equity % | 5.18 | 8.33 | 9.86 | 15.38 | 16.72 | |||||
Return on Common Equity | 5.18 | 8.37 | 9.87 | 15.55 | 16.87 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 43.53 | 43.03 | 41.7 | 46.76 | 48.06 | |||||
SG&A Margin | 11.07 | 9.73 | 8.6 | 9.53 | 9.53 | |||||
EBITDA Margin % | 32.05 | 32.92 | 32.55 | 36.81 | 38.38 | |||||
EBITA Margin % | 17.88 | 20.21 | 21.66 | 26.87 | 28.61 | |||||
EBIT Margin % | 15.07 | 17.86 | 19.95 | 25.2 | 26.93 | |||||
Income From Continuing Operations Margin % | 9.62 | 12.85 | 12.83 | 19.3 | 20.41 | |||||
Net Income Margin % | 9.18 | 12.42 | 12.43 | 18.87 | 19.89 | |||||
Net Avail. For Common Margin % | 9.17 | 12.41 | 12.43 | 18.87 | 19.89 | |||||
Normalized Net Income Margin | 8.89 | 10.78 | 12.27 | 15.17 | 16.13 | |||||
Levered Free Cash Flow Margin | 18.66 | 19.12 | 14.75 | 11.31 | 9.32 | |||||
Unlevered Free Cash Flow Margin | 19.21 | 19.47 | 15.15 | 12.09 | 10.24 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.31 | 0.36 | 0.41 | 0.41 | 0.41 | |||||
Fixed Assets Turnover | 0.91 | 1.08 | 1.3 | 1.32 | 1.29 | |||||
Receivables Turnover (Average Receivables) | 6.04 | 6.87 | 7.16 | 6.85 | 6.95 | |||||
Inventory Turnover (Average Inventory) | 8.98 | 10.13 | 10.48 | 8.55 | 8.44 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.8 | 0.74 | 0.79 | 0.8 | 0.89 | |||||
Quick Ratio | 0.61 | 0.56 | 0.63 | 0.62 | 0.68 | |||||
Operating Cash Flow to Current Liabilities | 0.54 | 0.71 | 0.54 | 0.59 | 0.65 | |||||
Days Sales Outstanding (Average Receivables) | 60.58 | 53.11 | 50.96 | 53.31 | 52.66 | |||||
Days Outstanding Inventory (Average Inventory) | 40.76 | 36.01 | 34.82 | 42.7 | 43.35 | |||||
Average Days Payable Outstanding | 75.51 | 68.62 | 60.21 | 62.27 | 59.59 | |||||
Cash Conversion Cycle (Average Days) | 25.82 | 20.51 | 25.57 | 33.74 | 36.42 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 34.74 | 33.49 | 45.4 | 49.43 | 57.26 | |||||
Total Debt / Total Capital | 25.78 | 25.09 | 31.23 | 33.08 | 36.41 | |||||
LT Debt/Equity | 26.11 | 26.59 | 31.05 | 34.34 | 40.77 | |||||
Long-Term Debt / Total Capital | 19.38 | 19.92 | 21.36 | 22.98 | 25.93 | |||||
Total Liabilities / Total Assets | 43.8 | 44.32 | 48.04 | 49.15 | 50.73 | |||||
EBIT / Interest Expense | 17.18 | 32.36 | 30.96 | 20.05 | 18.25 | |||||
EBITDA / Interest Expense | 36.54 | 61.49 | 51.84 | 29.97 | 26.64 | |||||
(EBITDA - Capex) / Interest Expense | 22.31 | 43.34 | 37.08 | 20.8 | 17.4 | |||||
Total Debt / EBITDA | 1.97 | 1.46 | 1.69 | 1.64 | 1.74 | |||||
Net Debt / EBITDA | 1.54 | 1.19 | 1.2 | 1.26 | 1.37 | |||||
Total Debt / (EBITDA - Capex) | 3.23 | 2.07 | 2.36 | 2.36 | 2.67 | |||||
Net Debt / (EBITDA - Capex) | 2.53 | 1.68 | 1.68 | 1.82 | 2.1 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -3.49 | 13.03 | 8.35 | -1.53 | 0.46 | |||||
Gross Profit, 1 Yr. Growth % | 2.38 | 11.72 | 5.01 | 10.41 | 3.25 | |||||
EBITDA, 1 Yr. Growth % | 8.57 | 16.08 | 7.15 | 11.36 | 4.83 | |||||
EBITA, 1 Yr. Growth % | 18.72 | 27.78 | 16.13 | 22.15 | 7.08 | |||||
EBIT, 1 Yr. Growth % | 21.91 | 33.97 | 21.01 | 24.37 | 7.5 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 15.4 | 50.88 | 8.22 | 48.12 | 6.24 | |||||
Net Income, 1 Yr. Growth % | 9.45 | 52.98 | 8.39 | 49.48 | 5.9 | |||||
Normalized Net Income, 1 Yr. Growth % | 17.44 | 37.09 | 23.36 | 21.71 | 6.98 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 17.5 | 55.74 | 12.43 | 52.98 | 8.18 | |||||
Accounts Receivable, 1 Yr. Growth % | -7.7 | 7.02 | 1.08 | 4.93 | -0.48 | |||||
Inventory, 1 Yr. Growth % | 1.89 | 0.23 | 14.14 | 6.93 | -7.99 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -0.96 | -9.34 | -9.62 | 4.38 | 1.07 | |||||
Total Assets, 1 Yr. Growth % | 1.87 | -7.51 | -2.39 | 1.45 | -0.82 | |||||
Tangible Book Value, 1 Yr. Growth % | -50.46 | 8.97 | -43.94 | -68.17 | 44.74 | |||||
Common Equity, 1 Yr. Growth % | -3.58 | -6.94 | -9.1 | -0.77 | -4.1 | |||||
Cash From Operations, 1 Yr. Growth % | 20.05 | 30.91 | -8.85 | 4.98 | 1.27 | |||||
Capital Expenditures, 1 Yr. Growth % | -7.66 | -9.24 | 2.82 | 19.35 | 18.75 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -26.13 | 15.83 | -16.45 | -24.49 | -17.09 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -25.62 | 14.56 | -15.69 | -21.39 | -14.81 | |||||
Dividend Per Share, 1 Yr. Growth % | 10.06 | 10.07 | 10.38 | 8.97 | 9.02 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 35.51 | 4.44 | 10.67 | 3.29 | -0.54 | |||||
Gross Profit, 2 Yr. CAGR % | 42.8 | 6.95 | 8.31 | 7.68 | 6.77 | |||||
EBITDA, 2 Yr. CAGR % | 46.93 | 12.26 | 11.53 | 9.24 | 8.01 | |||||
EBITA, 2 Yr. CAGR % | 41.58 | 23.16 | 21.81 | 19.1 | 14.32 | |||||
EBIT, 2 Yr. CAGR % | 36.15 | 27.8 | 27.33 | 22.68 | 15.57 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -21.8 | 31.95 | 27.78 | 26.6 | 25.45 | |||||
Net Income, 2 Yr. CAGR % | -24.44 | 29.4 | 28.77 | 27.29 | 25.82 | |||||
Normalized Net Income, 2 Yr. CAGR % | 36.38 | 26.89 | 30.04 | 22.53 | 14.05 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -39.38 | 35.28 | 32.33 | 31.15 | 28.64 | |||||
Accounts Receivable, 2 Yr. CAGR % | -2.78 | -0.61 | 4.01 | 2.99 | 0.57 | |||||
Inventory, 2 Yr. CAGR % | 2.33 | 1.06 | 6.96 | 10.47 | -0.81 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 0.14 | -5.24 | -9.48 | -2.87 | 2.71 | |||||
Total Assets, 2 Yr. CAGR % | -2.8 | -2.93 | -4.98 | -0.49 | 0.31 | |||||
Tangible Book Value, 2 Yr. CAGR % | -41.26 | -26.52 | -21.84 | -57.76 | -32.13 | |||||
Common Equity, 2 Yr. CAGR % | -4.24 | -5.27 | -8.02 | -5.03 | -2.45 | |||||
Cash From Operations, 2 Yr. CAGR % | 41.66 | 25.36 | 9.23 | -2.18 | 3.1 | |||||
Capital Expenditures, 2 Yr. CAGR % | 34.37 | -8.45 | -3.4 | 10.78 | 19.05 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 119.03 | -7.5 | -1.62 | -20.57 | -20.93 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 142.95 | -7.69 | -1.72 | -18.59 | -18.22 | |||||
Dividend Per Share, 2 Yr. CAGR % | 8.04 | 10.06 | 10.22 | 9.67 | 9 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 33.86 | 27.56 | 5.73 | 6.44 | 2.34 | |||||
Gross Profit, 3 Yr. CAGR % | 33.58 | 31.58 | 6.3 | 9.01 | 6.18 | |||||
EBITDA, 3 Yr. CAGR % | 33.34 | 35.83 | 10.53 | 11.47 | 7.72 | |||||
EBITA, 3 Yr. CAGR % | 23.44 | 36.82 | 20.77 | 21.93 | 14.91 | |||||
EBIT, 3 Yr. CAGR % | 18 | 35.42 | 25.5 | 26.33 | 17.35 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 26.09 | -2.65 | 23.51 | 34.23 | 19.42 | |||||
Net Income, 3 Yr. CAGR % | 26.11 | -4.41 | 21.98 | 35.33 | 19.72 | |||||
Normalized Net Income, 3 Yr. CAGR % | 19.15 | 36.61 | 25.7 | 27.2 | 17.06 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 2.85 | -16.97 | 27.19 | 38.88 | 23 | |||||
Accounts Receivable, 3 Yr. CAGR % | 37.21 | 0.38 | -0.05 | 4.32 | 0.74 | |||||
Inventory, 3 Yr. CAGR % | 41.21 | 1.63 | 5.24 | 6.95 | 3.94 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 36.08 | -3.12 | -6.72 | -5.08 | -1.57 | |||||
Total Assets, 3 Yr. CAGR % | 62.83 | -4.4 | -2.75 | -2.88 | -0.6 | |||||
Tangible Book Value, 3 Yr. CAGR % | 13.6 | -27.83 | -32.86 | -42.07 | -36.32 | |||||
Common Equity, 3 Yr. CAGR % | 98.85 | -5.14 | -6.57 | -5.67 | -4.72 | |||||
Cash From Operations, 3 Yr. CAGR % | 34.68 | 37.98 | 12.73 | 7.79 | -1.05 | |||||
Capital Expenditures, 3 Yr. CAGR % | 37.39 | 17.9 | -4.84 | 3.66 | 13.37 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 59.13 | 77.12 | -10.58 | -9.93 | -19.47 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 55.65 | 89.1 | -10.44 | -8.77 | -17.39 | |||||
Dividend Per Share, 3 Yr. CAGR % | 6.94 | 8.71 | 10.17 | 9.81 | 9.46 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 20.38 | 23.93 | 24.05 | 17.23 | 3.18 | |||||
Gross Profit, 5 Yr. CAGR % | 19.75 | 23.14 | 22.83 | 21.44 | 6.49 | |||||
EBITDA, 5 Yr. CAGR % | 19.6 | 24.12 | 24.15 | 24.49 | 9.51 | |||||
EBITA, 5 Yr. CAGR % | 14.19 | 20.87 | 22.78 | 29.44 | 18.14 | |||||
EBIT, 5 Yr. CAGR % | 10.77 | 18.86 | 21.65 | 30.17 | 21.42 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 10.51 | 20.8 | 26.76 | 8.14 | 24.28 | |||||
Net Income, 5 Yr. CAGR % | 10.08 | 20.6 | 27.17 | 7.19 | 23.5 | |||||
Normalized Net Income, 5 Yr. CAGR % | 11.23 | 20.04 | 23.39 | 30.8 | 20.9 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -2.56 | 7.04 | 13.76 | -0.31 | 27.77 | |||||
Accounts Receivable, 5 Yr. CAGR % | 23.61 | 24.99 | 22.81 | 1.42 | 0.2 | |||||
Inventory, 5 Yr. CAGR % | 26.63 | 25.8 | 26.36 | 5.08 | 2.78 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 22.06 | 18.68 | 15.61 | -3.02 | -3.06 | |||||
Total Assets, 5 Yr. CAGR % | 36.94 | 33.38 | 31.27 | -2.85 | -1.54 | |||||
Tangible Book Value, 5 Yr. CAGR % | 28.56 | 19.32 | -2.18 | -41.75 | -32.57 | |||||
Common Equity, 5 Yr. CAGR % | 60.89 | 54.38 | 46.08 | -5.1 | -4.94 | |||||
Cash From Operations, 5 Yr. CAGR % | 22.48 | 28.38 | 23.86 | 20.24 | 8.77 | |||||
Capital Expenditures, 5 Yr. CAGR % | 17.15 | 16.07 | 19.34 | 15 | 4.08 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 38.35 | 33.16 | 31.28 | 28.52 | -14.88 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 36.51 | 31.66 | 29.5 | 34.98 | -13.64 | |||||
Dividend Per Share, 5 Yr. CAGR % | 6.14 | 7.16 | 8.24 | 9.1 | 9.7 |
- Stock Market
- Equities
- LIN Stock
- Financials Linde plc
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















